Sign In
Buy NVO
$47.42
+1.52 (+3.31%)
At Close: Jun 23, 2026
Is a Beat on the Cards for Novo Nordisk (NVO) in Q4 Earnings?
12:02pm, Thursday, 26'th Jan 2023
Novo Nordisk's (NVO) top line is likely to have been driven by sales of its Diabetes and Obesity Care products in the fourth quarter of 2022.
2 Market-Beating Stocks to Buy in 2023 and Hold for 10 Years
09:53am, Thursday, 26'th Jan 2023
These two healthcare giants defied the bear market last year.
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
10:32am, Wednesday, 25'th Jan 2023
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
3 Reasons Growth Investors Will Love Novo Nordisk (NVO)
02:18pm, Friday, 20'th Jan 2023
Novo Nordisk (NVO) is well positioned to outperform the market, as it exhibits above-average growth in financials.
SNY vs. NVO: Which Stock Is the Better Value Option?
12:47pm, Monday, 16'th Jan 2023
SNY vs. NVO: Which Stock Is the Better Value Option?
Bet on These 5 Low Leverage Stocks Amid Easing Inflation
09:02am, Monday, 16'th Jan 2023
A prudent investor knows that if one wants to avoid huge losses in times of crisis, one needs to look for relatively safe bets. You may buy OXM, INGR, NVO, HP & FOXF.
Novo Nordisk: Momentum Continues While Valuation Remains 'Not Too' Expensive
09:37pm, Sunday, 15'th Jan 2023
Along with 2022 winner Eli Lilly, Novo Nordisk has been a market leader in a favored equity niche. Two key drugs continue to catch the allure of major Wall Street banks, and Novo is a highly-rated pic
State of California Sues Insulin Makers for Unfair Practices
12:48pm, Friday, 13'th Jan 2023
The lawsuit aims to curb the skyrocketing cost of insulin charged by insulin manufacturers and pharmacy benefit managers companies. The State also seeks to recover some monetary compensation.
How Novo Nordisk Just Expanded Its Diabetes Lead Over Pfizer, Eli Lilly
10:58am, Friday, 13'th Jan 2023
The Food and Drug Administration expanded the label for Novo Nordisk's oral diabetes medicine, leading NVO stock to jump Friday. The post How Novo Nordisk Just Expanded Its Diabetes Lead Over Pfizer,
Can Health Care Stocks Outperform Again In 2023?
06:09pm, Wednesday, 11'th Jan 2023
How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.
2 Top Biotech Stocks Defying the Bear Market
12:43pm, Tuesday, 10'th Jan 2023
Some stocks are hitting new highs.
Ranking The Top 10 Pharmaceuticals By Pipeline
11:44pm, Monday, 09'th Jan 2023
The pipeline is the heart of a drug discovery company. As such, analyzing the health of a pipeline can lead to suggestions about future performance.
Is Novo Nordisk (NVO) Stock Outpacing Its Medical Peers This Year?
11:17am, Friday, 06'th Jan 2023
Here is how Novo Nordisk (NVO) and Acumen Pharmaceuticals, Inc. (ABOS) have performed compared to their sector so far this year.
Novo Nordisk (NVO) Upgraded to Strong Buy: Here's Why
01:32pm, Thursday, 05'th Jan 2023
Novo Nordisk (NVO) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
New Strong Buy Stocks for January 5th
09:47am, Thursday, 05'th Jan 2023
AAL, DLNG, BNPQY, NVO and SAP have been added to the Zacks Rank #1 (Strong Buy) List on January 5 , 2023.
